Clover Health (CLOV) PT Raised to $3.50 at Citi
Tweet
Share
E-mail
Get Alerts CLOV Hot Sheet
Price: $4.30 +3.61%
Rating Summary:
2 Buy, 4 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Rating Summary:
2 Buy, 4 Hold, 3 Sell
Rating Trend: = Flat
Today's Overall Ratings:
Up: 10 | Down: 7 | New: 64
Join SI Premium – FREE
Citi analyst Jason Cassorla raised the price target on Clover Health (NASDAQ: CLOV) to $3.50 (from $3.00) while maintaining a Neutral rating.
Serious News for Serious Traders! Try StreetInsider.com Premium Free!
You May Also Be Interested In
- Designer Brands (DBI) PT Lowered to $6 at UBS
- Ascendis Pharma (ASND) PT Raised to $312 at Oppenheimer
- Comstock Resources (CRK) PT Raised to $20 at Mizuho
Create E-mail Alert Related Categories
Analyst PT ChangeRelated Entities
CitiSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
